I agree that this site is using cookies. You can find further informations here.
X
Gately, Ryan P
146  results:
Search for persons X
?
1

Midkine and chronic kidney disease-associated multisystem o..:

Campbell, Victoria K ; Gately, Ryan P ; Krishnasamy, Rathika...
Nephrology Dialysis Transplantation.  36 (2020)  9 - p. 1577-1584 , 2020
Link: https://doi.org/10.1093/..
 
?
2

Urine and serum midkine levels in an Australian chronic kid..:

Campbell, Victoria K ; Anstey, Chris M ; Gately, Ryan P...
BMJ Open.  7 (2017)  9 - p. e014615 , 2017
Link: https://doi.org/10.1136/..
 
?
3

Incidence of Thromboembolic Complications Following Kidney ..:

Pegle, Angus H ; Hegerty, Katharine ; Gately, Ryan P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276531/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
Cancers.  13 (2021)  9 - p. 2139 , 2021
Link: https://doi.org/10.3390/..
 
?
5

Targeting NF-κB-mediated inflammatory pathways in cisplatin..:

Ryan, Sarah-Louise ; Beard, Sam ; Barr, Martin P....
Lung Cancer.  135 (2019)  - p. 217-227 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125027/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Co-targeting PIM kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
https://eprints.qut.edu.au/233047/1/111969870.pdf.  , 2021
Link: https://eprints.qut.edu...
 
?
8

Targeting NF-KB-mediated inflammatory pathways in cisplatin..:

Ryan, Sarah Louise ; Beard, Sam ; Barr, Martin P...
https://eprints.qut.edu.au/200933/1/__qut.edu.au_Documents_StaffHome_StaffGroupH%24_henderm5_Desktop_1-s2.0-S016950021930529X-main.pdf.  , 2019
Link: https://eprints.qut.edu...
 
?
9

Targeting NF-κB-Mediated Inflammatory Pathways in Cisplatin..:

Ryan, S-L ; Beard, S ; Barr, MP...
https://discovery.ucl.ac.uk/id/eprint/10078144/8/Heavey_Targeting%20NF-%CE%BAB-Mediated%20Inflammatory%20Pathways%20in%20Cisplatin-Resistant%20NSCLC_AAM.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
10

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Gillian Moore ; Clara Lightner ; Samira Elbai...
https://www.mdpi.com/2072-6694/13/9/2139.  , 2021
Link: https://doi.org/10.3390/..
 
?
11

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Gillian Moore ; Clara Lightner ; Samira Elbai...
Cancer Therapy.  , 2021
Link: https://doi.org/10.3390/..
 
?
12

Quantification of tumor cell injuryin vitro andin vivo usin..:

Lin, Xinjian ; Gately, Dennis P. ; Hom, Doreen...
International Journal of Cancer.  91 (2001)  4 - p. 555-562 , 2001
Link: https://doi.org/10.1002/..
 
?
13

Increase in tumor GADD153 mRNA level following treatment co..:

de las Alas, Maida M. ; Christen, Randolph D. ; Gately, Dennis P....
Cancer Chemotherapy and Pharmacology.  45 (2000)  5 - p. 381-388 , 2000
Link: https://doi.org/10.1007/..
 
?
14

Paclitaxel Activation of the GADD153 Promoter through a Cel..:

Gately, Dennis P. ; Howell, Stephen B.
Journal of Biological Chemistry.  271 (1996)  34 - p. 20588-20593 , 1996
Link: https://doi.org/10.1074/..
 
?
15

Signaling and drug sensitivity:

Christen, Randolph D. ; Isonishi, Seiji ; Jones, Jeffrey A....
Cancer and Metastasis Reviews.  13 (1994)  2 - p. 175-189 , 1994
Link: https://doi.org/10.1007/..
 
1-15